MwanzoVEEV • NYSE
add
Veeva Systems Inc
$ 242.00
Baada ya Saa za Kazi:(1.00%)-2.43
$ 239.57
Imefungwa: 5 Des, 17:49:38 GMT -5 · USD · NYSE · Kanusho
Bei iliyotangulia
$ 242.33
Bei za siku
$ 239.16 - $ 244.22
Bei za mwaka
$ 201.54 - $ 310.50
Thamani ya kampuni katika soko
39.78B USD
Wastani wa hisa zilizouzwa
1.32M
Uwiano wa bei na mapato
47.07
Mgao wa faida
-
Ubadilishanaji wa msingi
NYSE
Kwenye habari
Fedha
Taarifa ya Mapato
Mapato
Mapato halisi
| (USD) | Okt 2025info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato | 811.24M | 16.02% |
Matumizi ya uendeshaji wa biashara | 370.92M | 7.99% |
Mapato halisi | 236.20M | 27.12% |
Kiwango cha faida halisi | 29.12 | 9.60% |
Mapato kwa kila hisa | 2.04 | 16.57% |
EBITDA | 250.56M | 30.99% |
Asilimia ya kodi ya mapato | 24.48% | — |
Taarifa ya Hali ya Kifedha
Jumla ya mali
Jumla ya dhima
| (USD) | Okt 2025info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Uwekezaji wa pesa taslimu na vipindi vifupi | 6.64B | 31.09% |
Jumla ya mali | 8.10B | 25.48% |
Jumla ya dhima | 1.06B | 11.04% |
Jumla ya hisa | 7.04B | — |
hisa zilizosalia | 164.38M | — |
Uwiano wa bei na thamani | 5.66 | — |
Faida inayotokana na mali | 7.48% | — |
Faida inayotokana mtaji | 8.69% | — |
Mtiririko wa pesa
Mabadiliko halisi ya pesa taslimu
| (USD) | Okt 2025info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato halisi | 236.20M | 27.12% |
Pesa kutokana na shughuli | 192.79M | 17.47% |
Pesa kutokana na uwekezaji | -495.23M | -66.06% |
Pesa kutokana na ufadhili | 32.65M | 151.90% |
Mabadiliko halisi ya pesa taslimu | -270.29M | -122.94% |
Mtiririko huru wa pesa | 80.87M | -36.28% |
Kuhusu
Veeva Systems Inc., headquartered in Pleasanton, California, provides cloud software, data, and business consulting for the life sciences industry. Its software is used to manage data, track regulatory registrations, and oversee supply chains. The company is a public benefit corporation.
The company has 1,477 customers including Bayer, Boehringer Ingelheim, Eli Lilly and Company, Gilead Sciences, Merck & Co., Novartis, Alkermes plc, Alnylam Pharmaceuticals, bluebird bio, and Idorsia. Its primary competitor for its customer relationship management software is Salesforce, which is partnered with IQVIA. Wikipedia
Afisa Mkuu Mtendaji (CEO)
Ilianzishwa
2007
Makao Makuu
Tovuti
Wafanyakazi
7,291
